Changed order that used someone else's brand

Legal entity that had applied for product registration using the Almada brand requested -- and was granted -- to change the name. At first, based on official information, it was thought that Adama would change its product. The issue is more complex. And it can be understood based on the history presented in the update of this article. 

UPDATE ON 23/04/2022, at 21:22 pm: Regarding the matter below, there is confusion surrounding the attempt to register a product based on a registered trademark belonging to Adama (it is not saying that there was bad faith; just that an attempt to register occurred). The chronology of the case is as follows... In 2011, Adama registered the Almada brand with INPI (priority on 01/12/2011). In 2016, another company requested registration of the Almada Pro product with the Ministry of Agriculture (Mapa). In 2020, Adama requested registration of the Almada product on Mapa. In 2022, the ministry granted Adama's request, which began marketing its product. In 2023, the other company requested that the name Almada Pro, included in its 2016 application, be changed to Asbelto Pro (this product is not yet registered on the Map).

The following text was published before it was possible to understand the situation narrated above...

Adama must change the commercial brand of the fungicide Almada to [...] (see note in the update above; there will be no change). The formulation remains the same: fluxapyroxad, mancozeb and prothioconazole. The original brand of the product was Cropper. Passed Almada. Thirdly, the same product also received authorization for marketing under the name Kejano. 

Almada has indications for use in soybean crops against: anthracnose (Colletotrichum truncatum), leaf blight (Cercospora kikuchii), Asian rust (Phakopsora pachyrhizi), target spot (Corynespora cassiicola), brown spot (Septoria glycones) and powdery mildew (Microsphaera diffusa).

Learn more about fluxapyroxad, mancozeb and prothioconazole

Fluxapyroxad (fluxapyroxad, Frac 7) is a succinate dehydrogenase inhibitor (SDHI). It interferes with several vital fungal functions, including spore germination, germ tube growth, appressorium formation, and mycelium growth. Specifically, it interferes with the production of succinate dehydrogenase, complex II in the mitochondrial respiration chain, which in turn interferes with the tricarboxylic cycle and mitochondrial electronic transport.

Mancozeb (mancozeb, Frac M03) reacts with the sulfhydryl groups of amino acids and enzymes within fungal cells, inactivating them and resulting in disruption of lipid metabolism, respiration, and adenosine triphosphate production. It is classified under the Frac code M:03. The letter "M" refers to chemical substances with activity at multiple sites. Frac groups with "M" are generally considered to be low risk and have no signs of developing fungicide resistance.

Prothioconazole (prothioconazole, Frac 3) has as its primary mechanism of action the inhibition of CYP51, a crucial component in the demethylation process of lanosterol or 24-methyl-dihydroanesterol at position 14. Interruption of this process results in an impaired biosynthesis mechanism of the ergosterol. Ergosterol is a precursor to vitamin D2, which is essential for cell membrane structure in many species of fungi. Studies also suggest that prothioconazole may interact with and temporarily suppress thyroid peroxidase. This enzyme is responsible for the formation of I2 from 2I-.